Come up with a name for your new list and we'll add to it:
Ignyta raised a round of funding on October 17, 2011. Investors include
City Hill Ventures.
Ignyta, formerly NexDx, specializes in precision medicine and biotechnology, with an integrated Rx/Dx approach in oncology, for the benefit of cancer patients everywhere.…